InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Praill Anthony Scott, 首席财务官. Officer active across 1 company, notably Kintara Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €17k. Activity tracked since 8 December 2021. The latest transaction was disclosed on 1 August 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Praill Anthony Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
240,087 股0Common StockSEC:0001493152-22-021172:0
28,700 股@ US$0.677100.0% 占其流量Common StockSEC:0000899243-21-047520:0
标准退出：2022年3月8日 (T+90)
2 条申报中的 2 条
About Praill Anthony Scott
Anthony Scott Praill is the Chief Financial Officer at Kintara Therapeutics, Inc. In this role, he is responsible for the company's financial management, including financial planning and reporting. Praill plays a key role in Kintara's financial strategy, contributing to its growth and profitability.
